Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on April 29, 2010. The report details the renewal of a material definitive agreement regarding the company's accounts receivables securitization facility.
Key Financial Metrics
- Facility Size: $700 million base limit.
- Seasonal Expansion: Option to increase commitments by an additional $250 million during December and March quarters, subject to bank approval.
- Purpose: Provides liquidity and funding for ongoing business needs based on pharmaceutical sales accounts receivables.
- Administrative Role: Bank of America, National Association, serves as the administrator.
Material Changes
The company renewed its accounts receivables securitization facility for an additional one-year term. The facility, previously expiring, now has a new expiration date of April 28, 2011. This renewal involved entering into an Amended and Restated Receivables Purchase Agreement and a First Amendment to the Receivables Sale Agreement.
Outlook and Management Commentary
Management indicates the facility is intended to support ongoing business needs. The filing does not provide specific forward-looking financial guidance, risk factors, or commentary on unusual items beyond the mechanics of the facility renewal.
Investor Verification Checklist
- Verify the total available liquidity under the facility ($700 million base + potential $250 million seasonal increase).
- Confirm the new expiration date of the facility (April 28, 2011).
- Review the terms of the Amended and Restated Receivables Purchase Agreement (Exhibit 99.1) for any changes in interest rates or covenants.
- Note that the registrant serves as the performance guarantor for the subsidiary's obligations under the facility.